Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Nutr Food Res ; 64(13): e2000005, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32415899

RESUMEN

SCOPE: Obesity is characterized by a dysfunction in the adipose tissue and an inflammatory subclinical state leading to insulin resistance and increased risk of cardiovascular diseases. It is also associated with intestinal dysbiosis that contributes to inflammation development. Lippia citriodora (LCE) contains high levels of polyphenolpropanoids and has shown promising results in obesity. The aim of this study is to investigate a well-characterized extract of LCE in a model of metabolic syndrome in mice, focusing on its effects on metabolic tissues, endothelial dysfunction, and microbiome. METHODS: Mice are fed a high fat diet (HFD) for six weeks and treated daily with LCE (1, 10, and 25 mg kg-1 ). Glucose and lipid metabolism is investigated. The inflammatory state in the metabolic tissues and the intestinal microbiota composition are characterized, as well as the endothelium-dependent vasodilator response to acetylcholine. RESULTS: LCE reduces fat accumulation and improves plasma glycemic and lipid profiles, as well as the inflammatory process and vascular dysfunction. Moreover, LCE lessens intestinal dysbiosis, as it reduces the Firmicutes/Bacteroidetes ratio and increases Akkermansia abundance in comparison with untreated HFD mice. CONCLUSION: The antiobesity therapeutic properties of LCE are most probably mediated by the synergic effects of its bioactive compounds.


Asunto(s)
Microbioma Gastrointestinal/efectos de los fármacos , Lippia/química , Obesidad/dietoterapia , Extractos Vegetales/farmacología , Animales , Fármacos Antiobesidad/química , Fármacos Antiobesidad/farmacología , Peso Corporal/efectos de los fármacos , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Disbiosis/dietoterapia , Disbiosis/microbiología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Microbioma Gastrointestinal/fisiología , Prueba de Tolerancia a la Glucosa , Lípidos/sangre , Masculino , Síndrome Metabólico/dietoterapia , Síndrome Metabólico/microbiología , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/microbiología , Extractos Vegetales/química
2.
Clin Nutr ; 29(2): 261-7, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19735963

RESUMEN

BACKGROUND & AIMS: Our aim was to compare the effects of intake of diets supplemented with different dietary fibers, namely cellulose, methylcellulose or Plantago ovata husks, (insoluble, soluble non-fermentable, and soluble fermentable fiber, respectively), on the abnormalities clustered in the metabolic syndrome. METHODS: Adult obese Zucker rats were distributed in four groups which were fed respectively a standard, a cellulose-supplemented, a methylcellulose-supplemented or a P. ovata husks-supplemented diet, for ten weeks. RESULTS: Increased body weight, hyperlipidemia, hyperinsulinemia and hyperleptinemia, increased TNF-alpha and reduced adiponectin secretion by adipose tissue found in obese Zucker rats were significantly improved in obese rats fed the P. ovata husks-supplemented diet, together with a lower hepatic lipid content which parallels activation of the signaling pathway of AMP-protein kinase in the liver. The methylcellulose-supplemented diet reduced body weight, hyperlipidemia, circulating free fatty acids concentration and ameliorated adipose tissue secretion of adiponectin and TNF-alpha. Feeding with the cellulose-supplemented diet only reduced free fatty acids circulating levels. CONCLUSIONS: The soluble dietary fibers essayed are more beneficial than insoluble fiber in the treatment of metabolic syndrome, being the soluble and fermentable the more efficient to improve metabolic alterations. Fermentation products of P. ovata husks must play an important role in such effects.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Fibras de la Dieta/administración & dosificación , Frutas/química , Síndrome Metabólico/dietoterapia , Síndrome Metabólico/fisiopatología , Obesidad/dietoterapia , Plantago/química , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Celulosa/administración & dosificación , Suplementos Dietéticos , Activación Enzimática , Fermentación , Grasa Intraabdominal/metabolismo , Hígado/enzimología , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/metabolismo , Metilcelulosa/administración & dosificación , Obesidad/sangre , Obesidad/metabolismo , Distribución Aleatoria , Ratas , Ratas Zucker , Solubilidad
3.
Obesity (Silver Spring) ; 16(9): 2081-7, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18551111

RESUMEN

The aim of this study was to analyze the effects of chronic administration of high doses of quercetin on metabolic syndrome abnormalities, including obesity, dyslipidemia, hypertension, and insulin resistance. For this purpose, obese Zucker rats and their lean littermates were used. The rats received a daily dose of quercetin (2 or 10 mg/kg of body weight) or vehicle for 10 weeks. Body weight and systolic blood pressure (SBP) were recorded weekly. At the end of the treatment, plasma concentrations of triglycerides, total cholesterol, free-fatty acids (FFAs), glucose, insulin, adiponectin, and nitrate plus nitrite (NOx) were determined. Tumor necrosis factor-alpha (TNF-alpha) production, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) protein expression were analyzed in visceral adipose tissue (VAT). The raised SBP and high plasma concentrations of triglycerides, total cholesterol, FFA, and insulin found in obese Zucker rats were reduced in obese rats that received either of the doses of quercetin assayed. The higher dose also improved the inflammatory status peculiar to this model, as it increased the plasma concentration of adiponectin, reduced NOx levels in plasma, and lowered VAT TNF-alpha production in obese Zucker rats. Furthermore, chronic intake of the higher dose of quercetin enhanced VAT eNOS expression among obese Zucker rats, whereas it downregulated VAT iNOS expression. In conclusion, both doses of quercetin improved dyslipidemia, hypertension, and hyperinsulinemia in obese Zucker rats, but only the high dose produced antiinflammatory effects in VAT together with a reduction in body weight gain.


Asunto(s)
Tejido Adiposo/efectos de los fármacos , Antioxidantes/farmacología , Síndrome Metabólico/tratamiento farmacológico , Obesidad/tratamiento farmacológico , Quercetina/farmacología , Adiponectina/sangre , Tejido Adiposo/enzimología , Tejido Adiposo/patología , Animales , Glucemia/metabolismo , Presión Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Ácidos Grasos no Esterificados/sangre , Insulina/sangre , Masculino , Síndrome Metabólico/metabolismo , Síndrome Metabólico/patología , Óxido Nítrico/sangre , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Óxido Nítrico Sintasa de Tipo III/biosíntesis , Obesidad/metabolismo , Obesidad/patología , Ratas , Ratas Zucker , Triglicéridos/sangre , Factor de Necrosis Tumoral alfa/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA